Parexel expands global clinical logistics capabilities

Wednesday, February 8, 2012 12:45 PM

Global CRO Parexel International is expanding its global clinical logistics services.

A new ancillary warehouse in the greater Boston area and a significantly enlarged depot in Santiago, Chile, will support the company’s ability to assist clients in more effectively managing their global clinical trial material supply requirements. These facilities expand on Parexel's existing clinical logistics infrastructure throughout North America, Latin America, Europe, Africa and the Asia/Pacific region.

"We are taking a strategic approach to the biopharmaceutical industry's steadily growing clinical logistics needs,” said Kurt Norris, corporate vice president, clinical research services for Parexel. “Through the expertise of our clinical logistics leaders around the world and our advanced global facilities we are focused on streamlining the clinical supply chain, and providing comprehensive services to our clients.”

Parexel clinical logistics experts manage import/export requirements, as well as end-to-end coordination of the clinical trial material supply chain from planning, sourcing, manufacturing, storage and distribution through to site management, return and destruction.

"Clinical trials are becoming more complex and sponsors find it challenging to organize consistent delivery of trial-related supplies to multiple locations around the world,” said Norris. “Expansion of our clinical logistics capabilities in North America and Latin America, in addition to ongoing investments in this area, reflect our commitment to bring greater efficiencies to global trial execution."

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs